Study | Year | Method of analysis | Nb of patients | FIGO stage | Macrometastatic SLN (%) | Micrometastatic SLN (%) |
---|---|---|---|---|---|---|
Maccauro | 2005 | H&E+SS+IHC | 26 | I-III | 4 (15) | 0 |
Delpech | 2007 | H&E+SS+IHC | 23 | I-II | 5 (21) | 3 (13) |
Delaloye | 2007 | H&E+SS+IHC | 60 | I-II-III | 8 (13) | 0 |
Lopes | 2007 | H&E+SS+IHC | 40 | I-II | 5 (12) | 2 (5) |
Ballester | 2008 | H&E+SS+IHC | 46 | I-II-III | 3 (6) | 7 (15) |
Bats | 2008 | H&E+SS+IHC | 43 | I-II-III | 8 (18) | 2 (4) |